Rawcliffe Adrian
CIK: 0001555851
Director
Primary company: Adaptimmune Therapeutics PLC (ADAP)
Rawcliffe Adrian is a corporate insider at Adaptimmune Therapeutics PLC (ADAP) filing SEC Form 4 transactions. 68 transactions across 2 companies, totaling $0 in purchases and $2,274,879 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Sale | 12,700 | $5.29 | $67K | 0 | 8/12/2026 Filed: 8/12/2026 | Filing → | |
| Exercise | 42,000 | - | - | 0 | 12/8/2025 Filed: 12/10/2025 | Filing → | |
| Sale | 42,000 | $15.00 | $630K | 12,700 | 12/8/2025 Filed: 12/10/2025 | Filing → | |
| Exercise | 42,000 | $5.97 | $251K | 54,700 | 12/8/2025 Filed: 12/10/2025 | Filing → | |
| Sale | 16,115 | $6.79 | $109K | 12,700 | 11/13/2025 Filed: 11/14/2025 | Filing → | |
| Award | 76,200 | - | - | 76,200 | 8/11/2025 Filed: 8/13/2025 | Filing → | |
| Award | 12,700 | - | - | 28,815 | 8/11/2025 Filed: 8/13/2025 | Filing → | |
Adaptimmune Therapeutics PLC ADAP | Award | 3,428,832 | $0.00 | $4K | 3,428,832 | 2/20/2025 Filed: 2/20/2025 | Filing → |
Adaptimmune Therapeutics PLC ADAP | Award | 5,143,248 | $0.10 | $514K | 5,143,248 | 2/20/2025 Filed: 2/20/2025 | Filing → |
Adaptimmune Therapeutics PLC ADAP | Sale | 30,601 | $0.58 | $18K | 44,327 | 1/17/2025 Filed: 1/17/2025 | Filing → |
Adaptimmune Therapeutics PLC ADAP | Sale | 29,096 | $0.57 | $17K | 41,582 | 1/15/2025 Filed: 1/15/2025 | Filing → |
Adaptimmune Therapeutics PLC ADAP | Sale | 17,934 | $0.59 | $11K | 25,711 | 1/13/2025 Filed: 1/15/2025 | Filing → |
Adaptimmune Therapeutics PLC ADAP | Sale | 12,539 | $0.59 | $7K | 17,801 | 1/13/2025 Filed: 1/15/2025 | Filing → |
| Award | 32,230 | - | - | 32,230 | 8/12/2024 Filed: 8/14/2024 | Filing → | |
| Award | 16,115 | - | - | 16,115 | 8/12/2024 Filed: 8/14/2024 | Filing → | |
Adaptimmune Therapeutics PLC ADAP | Sale | 30,080 | $0.67 | $20K | 44,848 | 1/17/2024 Filed: 1/17/2024 | Filing → |
Adaptimmune Therapeutics PLC ADAP | Sale | 9,304 | $0.79 | $7K | 14,104 | 1/16/2024 Filed: 1/17/2024 | Filing → |
Adaptimmune Therapeutics PLC ADAP | Award | 1,696,272 | - | - | 1,696,272 | 1/15/2024 Filed: 1/17/2024 | Filing → |
Adaptimmune Therapeutics PLC ADAP | Award | 7,633,296 | - | - | 7,633,296 | 1/15/2024 Filed: 1/17/2024 | Filing → |
Adaptimmune Therapeutics PLC ADAP | Sale | 17,257 | $0.85 | $15K | 26,388 | 1/12/2024 Filed: 1/12/2024 | Filing → |
Type
Sale
Shares
12,700
Price
$5.29
Value
$67K
Type
Exercise
Shares
42,000
Price
-
Value
-
Type
Sale
Shares
42,000
Price
$15.00
Value
$630K
Type
Exercise
Shares
42,000
Price
$5.97
Value
$251K
Type
Sale
Shares
16,115
Price
$6.79
Value
$109K
Type
Award
Shares
76,200
Price
-
Value
-
Type
Award
Shares
12,700
Price
-
Value
-
Adaptimmune Therapeutics PLC
ADAP
Type
Award
Shares
3,428,832
Price
$0.00
Value
$4K
Adaptimmune Therapeutics PLC
ADAP
Type
Award
Shares
5,143,248
Price
$0.10
Value
$514K
Adaptimmune Therapeutics PLC
ADAP
Type
Sale
Shares
30,601
Price
$0.58
Value
$18K
Adaptimmune Therapeutics PLC
ADAP
Type
Sale
Shares
29,096
Price
$0.57
Value
$17K
Adaptimmune Therapeutics PLC
ADAP
Type
Sale
Shares
17,934
Price
$0.59
Value
$11K
Adaptimmune Therapeutics PLC
ADAP
Type
Sale
Shares
12,539
Price
$0.59
Value
$7K
Type
Award
Shares
32,230
Price
-
Value
-
Type
Award
Shares
16,115
Price
-
Value
-
Adaptimmune Therapeutics PLC
ADAP
Type
Sale
Shares
30,080
Price
$0.67
Value
$20K
Adaptimmune Therapeutics PLC
ADAP
Type
Sale
Shares
9,304
Price
$0.79
Value
$7K
Adaptimmune Therapeutics PLC
ADAP
Type
Award
Shares
1,696,272
Price
-
Value
-
Adaptimmune Therapeutics PLC
ADAP
Type
Award
Shares
7,633,296
Price
-
Value
-
Adaptimmune Therapeutics PLC
ADAP
Type
Sale
Shares
17,257
Price
$0.85
Value
$15K
AI Agent
Try asking...